Skip to main content
. 2006 Jun;21(6):661–665. doi: 10.1111/j.1525-1497.2006.00399.x

Table 1.

Study Subjects

Demographics Social stress
Mean age 37.7   Eats regular meals 2246 (47.9%)
 Sex  Stress affects ability to take medicines 1142 (24.6%)
  Male 2871 (61.2%)
  Female 1823 (38.8%) Health care process
 Race/ethnicity  Receiving HAART 2707 (57.7%)
  White 610 (13.0%)  Length of time in clinic (mo) 64.0
  African American 4034 (85.9%)
  Other 50 (1.1%) Adherence
 HIV risk factor  Adherent to HAART* 2027 (74.9%)
  Male-to-male sex 1082 (23.1%)  Mean proportion missed appointments 0.127
  Heterosexual sex 1561 (33.3%)
  IVDU 2329 (49.6%) Health Status
 Mean LASA QOL 70.08
Substance use  HIV stage
 Alcohol past 6 mo 2043 (43.5%)   AIDS 2136 (45.9%)
 Cigarettes past 6 mo 3054 (66.5%)   Symptomatic 634 (13.6%)
 Any drugs past 6 mo 1132 (24.1%)  Asymptomatic 1885 (40.5%)
 Drug use ever 2961 (68.5%)  CD4 at time of interview 360
 RNA at time of interview 53735
Health beliefs  RNA less than 500 2150 (47.3%)
 Will live longer if take HIV medicines 1736 (37.0%)
 Will get sick if don't take medicines 1483 (31.6%)
 Medicines will prevent hospital admission 936 (20.0%)
 Medicines will prevent symptoms 1387 (29.6%)
*

Defined as not having missed any does for 3 d preceding interview, analysis limited to respondents on HAART.

HAART, highly active antiretroviral therapy; QOL, quality of life; LASA, linear analog scale assessment.